Nautilus Biotechnology (NAUT) Change in Acquisitions & Divestments (2020 - 2026)

Nautilus Biotechnology has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $29.9 million in Q2 2026.

• Quarterly Change in Acquisitions & Divestments rose 55.39% year-over-year to $29.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $118.8 million (down 19.6% YoY) and the FY2025 annual result came in at $109.0 million, down 29.87% from the prior year.
• Change in Acquisitions & Divestments rose to $29.9 million in Q2 2026 per NAUT's latest filing, from $25.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $67.0 million in Q2 2022 and troughed at $14.2 million in Q1 2023.
• A 5-year average of $30.8 million and a median of $27.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments soared 318.75% in 2022, then tumbled 73.13% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $21.1 million in 2022, then decreased by 3.55% to $20.3 million in 2023, then surged by 219.41% to $65.0 million in 2024, then plunged by 46.54% to $34.8 million in 2025, then slipped by 13.93% to $29.9 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $29.9 million, $25.8 million, and $34.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.